Stay updated on Ertugliflozin in Pediatric T2DM Clinical Trial
Sign up to get notified when there's something new on the Ertugliflozin in Pediatric T2DM Clinical Trial page.

Latest updates to the Ertugliflozin in Pediatric T2DM Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2 to the version history; removed the government funding notice and Revision: v3.4.1 from the history.SummaryDifference0.2%

- Check21 days agoChange DetectedAdded a notice about government funding lapse and operating status, and updated the revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check28 days agoChange DetectedUI improvements include showing the glossary, color-coded highlights legend, and updated revision footers (Revision: v3.4.0). No substantive study data or content was changed.SummaryDifference0.3%

- Check42 days agoChange DetectedAdded a new revision entry v3.3.4 and removed the previous entry v3.3.3 from the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedRevision label updated to v3.3.3 and the HHS Vulnerability Disclosure link removed; Revision: v3.3.2 was removed as well. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedA new revision entry v3.3.2 was added to the history, and the prior revision v3.3.1 was removed.SummaryDifference0.0%

Stay in the know with updates to Ertugliflozin in Pediatric T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ertugliflozin in Pediatric T2DM Clinical Trial page.